Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoHealth (GOCO) Shares Outstanding (Weighted Average) (2020 - 2025)

GoHealth's Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $14.1 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 40.28% year-over-year to $14.1 million; the TTM value through Sep 2025 reached $14.1 million, up 40.28%, while the annual FY2024 figure was $10.0 million, 7.4% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $14.1 million at GoHealth, up from $10.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $113.9 million in Q3 2021 and bottomed at $7.1 million in Q4 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $9.7 million (2024), against an average of $24.0 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) soared 139.29% in 2021 before it plummeted 92.72% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.1 million in 2021, then increased by 19.52% to $8.4 million in 2022, then rose by 10.03% to $9.3 million in 2023, then rose by 7.4% to $10.0 million in 2024, then skyrocketed by 41.64% to $14.1 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Shares Outstanding (Weighted Average) are $14.1 million (Q3 2025), $10.8 million (Q2 2025), and $10.4 million (Q1 2025).